Smart radiation aims to zap liver tumors with fewer side effects
NCT ID NCT05027711
First seen Mar 11, 2026 · Last updated May 27, 2026 · Updated 9 times
Summary
This study tests whether a newer, more precise type of radiation (MR-guided adaptive radiotherapy) can treat liver tumors that have spread from other cancers with fewer side effects than standard radiation. About 90 adults with 1 to 3 small liver metastases will be enrolled. The key goal is to see if the new approach reduces serious stomach or liver side effects while still controlling the tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
Contact
Conditions
Explore the condition pages connected to this study.